ELLA CHEBAN: Open Payments
NPI 1477269868 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 49 payments from 21 companies in 2025. Trend: 2023 $1,026 · 2024 $1,802 · 2025 $1,160
Food & beverage: $1,131Education: $29
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $207 |
| PFIZER INC. | 6 | $109 |
| CSL Behring | 3 | $81 |
| Amgen Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $76 |
| Amneal Pharmaceuticals LLC | 3 | $72 |
| UCB, Inc. | 2 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Lilly USA, LLC | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
Products named: REXULTI, NURTEC ODT, Hizentra, CREXONT, Briviact, QULIPTA, KESIMPTA, AMYVID.
Industry payments across NC — which companies pay providers there.
